Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine liposome versus ropivacaine low serratus anterior plane block for analgesia after laparoscopic nephrectomy
ChiCTR2600134800Phase 4Completed
- Sponsor
- First Affiliated Hospital of Nanchang University
- Start
- Aug 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial of liposomal bupivacaine and ropivacaine in acute pain (2 arms), sponsored by First Affiliated Hospital of Nanchang University. Primary endpoint: Opioid consumption within 72 hours after surgery. Started Aug 2025; status: completed.
02
Drugs
liposomal bupivacaineropivacaine
03
Conditions
acute pain
Beyond the preview
Go deeper on ChiCTR2600134800.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600134800.